First Time Loading...

Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 104 GBX
Updated: Apr 18, 2024

Intrinsic Value

Diaceutics Plc engages in the provision of data, data analytics and implementation services. [ Read More ]

The intrinsic value of one DXRX stock under the Base Case scenario is 92.68 GBX. Compared to the current market price of 104 GBX, Diaceutics PLC is Overvalued by 11%.

Key Points:
DXRX Intrinsic Value
Base Case
92.68 GBX
Overvaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Diaceutics PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DXRX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Diaceutics PLC

Provide an overview of the primary business activities
of Diaceutics PLC.

What unique competitive advantages
does Diaceutics PLC hold over its rivals?

What risks and challenges
does Diaceutics PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Diaceutics PLC.

Provide P/S
for Diaceutics PLC.

Provide P/E
for Diaceutics PLC.

Provide P/OCF
for Diaceutics PLC.

Provide P/FCFE
for Diaceutics PLC.

Provide P/B
for Diaceutics PLC.

Provide EV/S
for Diaceutics PLC.

Provide EV/GP
for Diaceutics PLC.

Provide EV/EBITDA
for Diaceutics PLC.

Provide EV/EBIT
for Diaceutics PLC.

Provide EV/OCF
for Diaceutics PLC.

Provide EV/FCFF
for Diaceutics PLC.

Provide EV/IC
for Diaceutics PLC.

Show me price targets
for Diaceutics PLC made by professional analysts.

What are the Revenue projections
for Diaceutics PLC?

How accurate were the past Revenue estimates
for Diaceutics PLC?

What are the Net Income projections
for Diaceutics PLC?

How accurate were the past Net Income estimates
for Diaceutics PLC?

What are the EPS projections
for Diaceutics PLC?

How accurate were the past EPS estimates
for Diaceutics PLC?

What are the EBIT projections
for Diaceutics PLC?

How accurate were the past EBIT estimates
for Diaceutics PLC?

Compare the revenue forecasts
for Diaceutics PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Diaceutics PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Diaceutics PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Diaceutics PLC compared to its peers.

Compare the P/E ratios
of Diaceutics PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Diaceutics PLC with its peers.

Analyze the financial leverage
of Diaceutics PLC compared to its main competitors.

Show all profitability ratios
for Diaceutics PLC.

Provide ROE
for Diaceutics PLC.

Provide ROA
for Diaceutics PLC.

Provide ROIC
for Diaceutics PLC.

Provide ROCE
for Diaceutics PLC.

Provide Gross Margin
for Diaceutics PLC.

Provide Operating Margin
for Diaceutics PLC.

Provide Net Margin
for Diaceutics PLC.

Provide FCF Margin
for Diaceutics PLC.

Show all solvency ratios
for Diaceutics PLC.

Provide D/E Ratio
for Diaceutics PLC.

Provide D/A Ratio
for Diaceutics PLC.

Provide Interest Coverage Ratio
for Diaceutics PLC.

Provide Altman Z-Score Ratio
for Diaceutics PLC.

Provide Quick Ratio
for Diaceutics PLC.

Provide Current Ratio
for Diaceutics PLC.

Provide Cash Ratio
for Diaceutics PLC.

What is the historical Revenue growth
over the last 5 years for Diaceutics PLC?

What is the historical Net Income growth
over the last 5 years for Diaceutics PLC?

What is the current Free Cash Flow
of Diaceutics PLC?

Financials

Balance Sheet Decomposition
Diaceutics PLC

Current Assets 28m
Cash & Short-Term Investments 17.9m
Receivables 9.2m
Other Current Assets 874k
Non-Current Assets 18.2m
PP&E 2m
Intangibles 16.1m
Other Non-Current Assets 96k
Current Liabilities 3.5m
Accounts Payable 287k
Accrued Liabilities 1.7m
Other Current Liabilities 1.5m
Non-Current Liabilities 1.6m
Long-Term Debt 1.1m
Other Non-Current Liabilities 429k
Efficiency

Earnings Waterfall
Diaceutics PLC

Revenue
21.9m GBP
Cost of Revenue
-1.6m GBP
Gross Profit
20.3m GBP
Operating Expenses
-20.9m GBP
Operating Income
-528k GBP
Other Expenses
534k GBP
Net Income
6k GBP

Free Cash Flow Analysis
Diaceutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

DXRX Profitability Score
Profitability Due Diligence

Diaceutics PLC's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Declining ROIC
42/100
Profitability
Score

Diaceutics PLC's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

DXRX Solvency Score
Solvency Due Diligence

Diaceutics PLC's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Diaceutics PLC's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DXRX Price Targets Summary
Diaceutics PLC

Wall Street analysts forecast DXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXRX is 169.93 GBX with a low forecast of 146.45 GBX and a high forecast of 210 GBX.

Lowest
Price Target
146.45 GBX
41% Upside
Average
Price Target
169.93 GBX
63% Upside
Highest
Price Target
210 GBX
102% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

DXRX Price
Diaceutics PLC

1M 1M
+2%
6M 6M
+13%
1Y 1Y
-1%
3Y 3Y
-17%
5Y 5Y
+9%
10Y 10Y
+9%
Annual Price Range
104
52w Low
80.5
52w High
109
Price Metrics
Average Annual Return -2.76%
Standard Deviation of Annual Returns 28.92%
Max Drawdown -60%
Shares Statistics
Market Capitalization 87.9m GBX
Shares Outstanding 84 679 296
Percentage of Shares Shorted
N/A

DXRX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Diaceutics PLC Logo
Diaceutics PLC

Country

United Kingdom

Industry

Life Sciences Tools & Services

Market Cap

87.9m GBP

Dividend Yield

0%

Description

Diaceutics Plc engages in the provision of data, data analytics and implementation services. The company is headquartered in Belfast, Northern Ireland. The company went IPO on 2019-03-21. The principal activity of the Company is data analytics and implementation services. The firm is engaged in research and development activities in drug development science, testing data and software platform development. The firm's implementation services include test standardization, test quality assessment, laboratory tech support and others. The firm has established a range of products and outsourced advisory services, which help its pharma clients to optimize and deliver their marketing and implementation strategies for companion diagnostics. The firm provides the pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX - The Diagnostic Network. DXRX is the diagnostic commercialization platform for precision medicine, integrating multiple pipelines of diagnostic testing data from a global network of laboratories.

Contact

NORTHERN IRELAND
Belfast
Titanic Suites Enterprise House, 55-59 Adelaide Street
https://www.diaceutics.com/

IPO

2019-03-21

Employees

120

Officers

CEO & Director
Mr. Ryan Keeling
Founder & Executive Director
Mr. Peter Keeling
CFO & Director
Mr. Nicholas Stewart Roberts
Chief Operating Officer
Ms. Julie Browne
General Counsel
Ms. Gillian Shaw
Global Head of Human Resources
Ms. Norma Thompson
Show More
Chief Precision Medicine Officer
Ms. Susanne Munksted
Chief Commercial Officer
Ms. Jillian Beggs
Senior Director & Head of Data Delivery Netherlands
Ms. Marieke Hoefsmit
Show Less

See Also

Discover More
What is the Intrinsic Value of one DXRX stock?

The intrinsic value of one DXRX stock under the Base Case scenario is 92.68 GBX.

Is DXRX stock undervalued or overvalued?

Compared to the current market price of 104 GBX, Diaceutics PLC is Overvalued by 11%.